BioSig Technologies and Streamex Successfully Close $15 Million Offering

Author: Dylan Bailey Updated: 08-15-2025 05:00 PM

BioSig Technologies and Streamex Close $15 Million Offering

BioSig Technologies, Inc. is excited to share that it has successfully completed a public offering, raising approximately $15 million. The company, now merged with Streamex Exchange Corporation (NASDAQ: BSGM), focuses on gold tokenization infrastructure, positioning itself as a leader in the industry.

Details of the Offering

The latest offering included 3,852,149 shares of common stock priced at $3.90 each. This strategic move aimed to bolster BioSig’s resources, generating gross proceeds of around $15 million. The funds will primarily be used for purchasing gold bullion, adhering to BioSig’s investment policy, and enhancing the company's operational capital.

Growth and Investment Strategy

Henry McPhie, CEO of BioSig and Co-Founder of Streamex, mentioned that the strong capital strategy they’ve now established will help secure the company’s future in this pivotal phase. With the backing of quality shareholders, BioSig aims to accelerate value creation for investors as it expands within the gold bullion market.

Strategic Partnerships

Clear Street and Needham & Company played vital roles as joint book-running managers in this offering. Their expertise and insights have been instrumental in ensuring a successful outcome for BioSig.

Regulatory Compliance

The public offering was conducted in accordance with a shelf registration statement filed with the Securities and Exchange Commission (SEC). A final prospectus supplement, along with a base prospectus, is available for investors seeking more details about this opportunity.

The Future of Streamex

Streamex is dedicated to building institutional-grade infrastructure that integrates the gold market with blockchain technology. By doing so, it aims to create a gold-denominated treasury and enhance investor access to tokenization.

About BioSig Technologies

As a forefront medical device technology company, BioSig Technologies offers the advanced PURE EP™ Platform. This platform enables electrophysiologists to capture real-time data, free from noise, ensuring precision in ablation treatments for cardiovascular arrhythmias. The effectiveness of the PURE EP™ system presents significant benefits by maximizing procedural efficacy while minimizing costs.

Frequently Asked Questions

What was the total amount raised in BioSig's public offering?

BioSig Technologies raised approximately $15 million through its public offering with Streamex.

What is the purpose of the funds raised from the offering?

The proceeds will be used to purchase gold bullion, support general corporate purposes, and enhance working capital for BioSig Technologies.

Who are the joint book-running managers for the offering?

Clear Street and Needham & Company acted as joint book-running managers for BioSig’s public offering.

What is Streamex's role within BioSig Technologies?

Streamex focuses on bringing the gold market on-chain, utilizing a gold-denominated treasury to promote tokenization and investment opportunities.

How does the PURE EP™ Platform benefit electrophysiologists?

The PURE EP™ Platform allows electrophysiologists to obtain clear, real-time signal data, increasing procedural success while reducing inefficiencies and costs.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.